Durable T-cellular and humoral responses in SARS-CoV-2 hospitalized and community patients.

Kristin Greve-Isdahl Mohn Geir BredholtFan ZhouAnders MadsenTherese B OnyangoElisabeth B FjelltveitSarah L JallohKarl A BrokstadDiego Cantoni Martin Mayora NetoNigel TempertonNina LangelandRebecca J Coxnull null

Published in: PloS one (2022)

SARS-CoV-2 specific T-cellular and antibody responses persisted for 6 months post confirmed infection. In previously infected patients, re-exposure or vaccination will boost long-term immunity, possibly providing protection against re-infection with variant viruses.

Keyphrases

sars cov
end stage renal disease
respiratory syndrome coronavirus
immune response
chronic kidney disease
ejection fraction
newly diagnosed
healthcare
peritoneal dialysis
prognostic factors
mental health
coronavirus disease
patient reported